VALIDATION STUDY
Add like
Add dislike
Add to saved papers

Diagnostic criteria for Gianotti-Crosti syndrome: a prospective case-control study for validity assessment.

No criteria exist for the modern diagnosis of Gianotti-Crosti syndrome (GCS). Our study objectives were to determine diagnostic criteria for GCS and to assess their validity using a prospective case-control design. We reviewed the clinical features of children with GCS who were reported in the literature from 1996 to 2000 and proposed a set of diagnostic criteria. We documented clinical features of children younger than 18 years who were diagnosed over a period of 18 months as having GCS and of control subjects given (over the same period) differential diagnoses of GCS. Forty-two children were recruited (11 with GCS and 31 controls with differential diagnoses of GCS). All children with GCS, and none of the controls, fulfilled the set of diagnostic criteria as a whole. We conclude that the proposed criteria are practical valid criteria for diagnosing GCS.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app